Trials / Unknown
UnknownNCT04592835
To Evaluate the Safety, Tolerability and Pharmacokinetic Properties of DWRX2003
A Double-blind, Randomized, Placebo-controlled, Single-ascending Dose Phase I Study to Evaluate the Safety, Tolerability and Pharmacokinetic Properties of Niclosamide Injectable (DWRX2003) Following Intramuscular Administration in Healthy Volunteers
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 24 (estimated)
- Sponsor
- Daewoong Pharmaceutical Co. LTD. · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
This study is designed to assess the safety, tolerability and Pharmacokinetic Properties of Niclosamide Injectable (DWRX2003) in healthy volunteers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | DWRX2003 | Intramuscularly injection at predefined injection sites Drug: Placebo Intramuscularly injection at predefined injection sites |
Timeline
- Start date
- 2020-10-19
- Primary completion
- 2020-12-13
- Completion
- 2021-06-30
- First posted
- 2020-10-19
- Last updated
- 2020-10-19
Source: ClinicalTrials.gov record NCT04592835. Inclusion in this directory is not an endorsement.